Steven M. Fruchtman
2015
In 2015, Steven M. Fruchtman earned a total compensation of $913.2K as Chief Medical Officer and Senior Vice President, Research and Development at Onconova Therapeutics.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $459,904 |
| Salary | $395,769 |
| Other | $7,528 |
| Total | $913,201 |
Fruchtman received $459.9K in option awards, accounting for 50% of the total pay in 2015.
Fruchtman also received $50K in bonus, $395.8K in salary and $7.5K in other compensation.
Rankings
In 2015, Steven M. Fruchtman's compensation ranked 8,380th out of 13,638 executives tracked by ExecPay. In other words, Fruchtman earned more than 38.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,380 out of 13,638 | 39th |
Division Manufacturing | 3,195 out of 5,190 | 38th |
Major group Chemicals And Allied Products | 1,161 out of 1,854 | 37th |
Industry group Drugs | 938 out of 1,528 | 39th |
Industry Pharmaceutical Preparations | 735 out of 1,182 | 38th |
Source: SEC filing on April 12, 2017.
Fruchtman's colleagues
We found two more compensation records of executives who worked with Steven M. Fruchtman at Onconova Therapeutics in 2015.
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019